Navigation

Investiment.io
Financial analysis platform

Thermo Fisher Scientific Inc.

TMO โ€ข NYSE

$691.33
โ–ผ8.89 (1.27%)โ€ข REGULAR

Thermo Fisher Scientific Inc.

$691.33
โ–ผ1.3%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading

๐Ÿ“ˆ Advanced DCF Valuation

Professional-grade discounted cash flow analysis with scenario modeling for TMO

Healthcare โ€ข Diagnostics & Research โ€ข Market Cap: $256,148,735,024.44

Scenario Analysis

Compare different scenarios to understand valuation sensitivity

๐Ÿ”ป-82.7% upside

Conservative Case

$119.81

๐Ÿ“Š-73.7% upside

Base Case

$181.84

๐Ÿ”บ-64.1% upside

Optimistic Case

$248.15

๐Ÿ’ฐMarket Price

Current Price

$691.33

DCF Model & Results

Detailed cash flow projections and valuation analysis

๐Ÿ’ต Enhanced Cash Flow Projections

YearRevenueGrowth %Operating Margin %NOPATCapExFCFPV of FCF
1$46,783,800,000.005.0%17.4%$6,425,307,000.00$1,641,281,250.00$6,176,400,750.00$5,665,139,968.46
2$48,655,152,000.004.0%17.4%$6,682,319,280.00$1,613,675,700.00$6,518,941,380.00$5,484,378,638.04
3$50,358,082,320.003.5%17.4%$6,916,200,454.80$1,582,757,792.24$6,835,670,480.56$5,274,807,939.55
4$51,868,824,789.603.0%17.4%$7,123,686,468.44$1,544,923,269.98$7,127,274,229.81$5,044,570,300.44
5$53,165,545,409.342.5%17.4%$7,301,778,630.16$1,500,663,691.69$7,389,597,697.64$4,797,297,838.31
Terminalโ€”3.0%โ€”โ€”โ€”$115,744,343,311.28$75,140,773,650.04
Enterprise Value$101,406,968,334.82
Net Debt$32,853,000,000.00
Equity Value$68,553,968,334.82
Price per Share$181.84
EV/Revenue (Final Year)1.9x
Terminal Value %74.1%
WACC9.0%

๐Ÿฅ Company Financial Health

Historical Revenue Growth3.5%
Current Operating Margin17.4%
FCF Conversion Rate14.1%
Net Debt/Equity0.00
ROE0.0%
ROIC0.0%
Beta1.20
Interest Coverage0.00
Enhanced DCF data sourced from Financial Modeling Prep (FMP) โ€ข Model incorporates industry best practices and academic research โ€ข Calculations are estimates and should not be used as sole investment advice โ€ข Consult with a financial advisor before making investment decisions